Scalp block for headache after aneurysmal subarachnoid hemorrhage in ICU patients
Official title: Efficacy of Scalp Block in Managing Post Subarachnoid Hemorrhage Headache in Critically Ill Patients. A Single Centre Randomized Controlled Trial
Run by Hamad Medical Corporation · NCT07307508 · Data updated 2026-11-12
We are testing whether a levobupivacaine scalp block added to standard pain medicines can reduce severe headache in adults in the ICU after aneurysmal subarachnoid hemorrhage treated endovascularly.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 22 (estimated) |
| Sponsor | Hamad Medical Corporation Industry-sponsored |
| Locations | 1 site (Doha) |
| Status | Recruiting |
| Started | October 22, 2025 |
| Main results expected | July 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | December 29, 2025 |
| Trial ID | NCT07307508 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 admitted to the SICU with aneurysmal subarachnoid hemorrhage who underwent endovascular aneurysm treatment, are neurologically stable/awake (GCS >13), and have no chronic headache, bleeding disorder, pregnancy, or allergy to local anesthetics.
✕Probably not a fit
Patients who had surgical clipping, non-aneurysmal hemorrhage, low consciousness (GCS ≤13 or WFNS 4–5), prolonged mechanical ventilation, chronic headache disorders, bleeding disorders, pregnancy, or local anesthetic allergy are excluded and unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center randomized controlled trial at Hamad Medical Corporation compares a levobupivacaine scalp block plus conventional analgesic therapy versus conventional analgesics alone for adults with aneurysmal subarachnoid hemorrhage treated by endovascular methods. Eligible participants are adults admitted to the surgical ICU who are awake and meet neurological stability criteria, while patients with surgical clipping, chronic headache disorders, bleeding disorders, pregnancy, or local anesthetic allergy are excluded. The intervention delivers regional scalp anesthesia and investigators will measure headache severity, opioid consumption, ICU course, and adverse events during hospitalization. Patients are randomly assigned to one of the two arms and treated according to standardized analgesic protocols.
Why it matters
Potential benefit: If successful, this approach could provide faster and stronger headache relief and reduce opioid use and ICU-related complications after aSAH.
How similar studies have gone: Small case series and observational reports have suggested scalp blocks can relieve post-SAH headache, but randomized controlled evidence is currently lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All adults \> 18 years who are admitted to the Surgical Intensive Care Unit (SICU) with a confirmed diagnosis of aneurysmal subarachnoid hemorrhage, undergoing endovascular treatment of the aneurysm (coiling/flow diversion). Exclusion Criteria: 1. Patients with aSAH undergoing surgical craniotomy and aneurysmal clipping. 2. Non-aneurysmal subarachnoid or other intracranial hemorrhage forms (e.g., Intracerebral hemorrhage). 3. SICU admission Glasgow Coma Scale (GCS) of 13 or lower. 4. WFNS Score 4 / 5 or requiring mechanical ventilation for more than 24 hrs. 5. Patients with known allergy to local anesthetics. 6. Admission to ICU \> 7 days after hemorrhage. 7. Patients with a documented bleeding disorder. 8. Patients with a history of chronic headache disorder or migraine. 9. Pregnancy
Where it's running
-
Hamad Medical Corporation
Doha, Qatar Recruiting
Study contacts
- Principal investigator: Sohel Mohamed Ahmed, Consultant — Hamad Medical Corporation
- Study coordinator: Sohel Mohamed Ahmed, Consultant
- Email: SAhmed65@hamad.qa
- Phone: +97450586481
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases
This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.
-
Personality traits, thinking skills, and pain sensitivity in people with headache
This project will see how personality, cognitive function, and central sensitization relate to pain severity, symptom change, and treatment adherence over six months in adults with chronic or episodic headache.
-
Tracking delayed ischemic neurological deficits in people with aneurysmal subarachnoid hemorrhage — real-world data
This project will collect real-world monitoring and treatment information to see how often delayed ischemic neurological deficits (DIND) happen and what diagnostic and treatment approaches people with aneurysmal subarachnoid hemorrhage receive.
-
Intranasal sphenopalatine ganglion block for headache after a ruptured brain aneurysm
This will test whether spraying a numbing medicine into the back of the nose can reduce severe headache in adults recovering from a ruptured brain aneurysm.
-
New methods to test preventive migraine treatment
This trial will test how the active medicine, placebo injections, and the information given about them affect symptoms in adults with chronic migraine.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.